Trial Type: Lymphoma

SUNMO: A Randomized, Open-Label, Multicenter Phase III Study Evaluating Efficacy And Safety Of Mosunetuzumab In Combination With Polatuzumab Vedotin In Comparison With Rituximab In Combination With Gemcitabine Plus Oxaliplatin In Participants With Relapsed Or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma

A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy with Immuno-oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma

A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination with Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma

Effects of Maplirpacept (PF-07901801),Tafasitamab, and Lenalidomide in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma. (NCT05626322)

A Multi-Center, Open-Label, Phase 1/2 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-101 Monotherapy and AB-101 with Immunotherapy in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma of B-Cell Origin. (NCT04673617)

A Phase 1, Multicenter, Open-Label, Dose-Escalation and Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Intravenously Administered KT-333 in Adult Patients with Relapsed or Refractory Lymphomas, Large Granular Lymphocytic Leukemia, and Solid Tumors

A Phase 1, Open-Label, Multicenter, Dose Escalation Study of SGR-1505, a MALT1 inhibitor, As Monotherapy in Subjects with Mature B-Cell Malignancies including CLL

A Randomized Phase II Study of CHO(E)P Vs CC-486-CHO(E)P Vs Duvelisib-CHO(E)P in Previously Untreated CD30 Negative Peripheral T-Cell Lymphomas

An open-label phase II study to investigate the efficacy, safety, and pharmacokinetics of tirabrutinib in patients with Primary Central Nervous System Lymphoma (PCNSL)

Phase I Trial of Methotrexate, Rituximab, Lenalidomide, and Nivolumab (Nivo-MR2) Induction Followed by Lenalidomide and Nivolumab Maintenance in Primary CNS Lymphoma